OPEN END TURBO LONG - HALEON Share Price

Certificat

DE000MD8R280

Market Closed - Börse Stuttgart 11:31:48 28/06/2024 BST
0.38 EUR -11.63% Intraday chart for OPEN END TURBO LONG - HALEON
Current month+2.70%
1 month-2.56%
Date Price Change
28/06/24 0.38 -11.63%
27/06/24 0.43 -2.27%
26/06/24 0.44 -6.38%
25/06/24 0.47 0.00%
24/06/24 0.47 +4.44%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:31 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MD8R28
ISINDE000MD8R280
Date issued 29/09/2022
Strike 295.9 p
Maturity Unlimited
Parity 1 : 1
Emission price 0.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.98
Lowest since issue 0.031

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.226 GBP
Average target price
3.646 GBP
Spread / Average Target
+13.03%
Consensus